Abstract

IMPACT OF CLINICAL PHARMACIST ON PHARMACEUTICAL CARE AND QUALITY OF LIFE IN PSORIASIS VULGARIS

Bala Murali Mohan. S, Naresh. T*, Krishna Kanth. T, Parimalakrishnan. S,Kaviarasan.PK

ABSTRACT

Background:Psoriasis is a chronic inflammatory and proliferative condition of the skin which has a significant negative impact on QoL.Objectives:The aim of the study is to assess the impact of psoriasis on QoL, clinical outcome and cost of illness.Materials and Methods:It was a non-invasive observational prospective study conducted in a 1400 bedded multi-speciality tertiary care teaching hospital at Chidambaram, South India for 6 months. Totally 48 patients were observed by using WHOQoL questionnaire for assessing the QoL, Psoriasis Area Severity Index (PASI) for severity of disease, Beck’s anxiety and depression scales for estimating the psychiatric condition of the patient.Results:In our study, majority belongs to the age group of 51-60 years (26.78%). The mean age of patients was 47.68±13.83 in males and 40.62±12.67 in females. From PASI, the most exposed area was lower limbs (92.85%). 57.14% of the patients were farmers. The patients were more with very low anxiety (73%) and only 2 out of 48 patients were suffering from severe depression.Two follow-ups were performed in our study, the mean scores were calculated which gradually increased from base line to follow up, this states that QoL was increased after counselling and particularly in females.The QoL was increased more in the age group of 41-50. The QoL was decreased as the no.of drugs prescribed were increased and as the duration of the disease increased. In our study, the direct cost (53.90%) was more than indirect cost (46.10%). Conclusion:Counselling plays an important role in the patient’s QoL, as the results clearly shown an increment in the QoL of patients after counselling. The involvement of healthcare workers had significantly improved the QoL of patients. Therefore from this study a significant impact of clinical pharmacist on QoL was observed.

Keywords: Psoriasis, Pharmaceutical care, PASI, WHOQoL, Quality of life.